US Consumer Prices Rise 38 in April Exceeding Expectations and Marking Highest Since May 2023 Chinas Crypto Crackdown Faces Persistent CatandMouse Game US Government Stake Speculation Intensifies IonQ Micron Anduril Emerge as Top Candidates Energy Experts Advise Early Action to Reduce Winter Heating Bills TrumpConnected Stock Trades Draw Scrutiny Over Potential Conflicts Geosphere Capitals Arvind Sanger Cautiously Optimistic on Indian Markets Eyes Earnings Revival REPL Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues FMBH Q1 2026 Earnings Earnings Per Share Beats Estimates by 531 Century Aluminum Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction T Stamp IDAI Q1 2026 Earnings EPS Miss Widens as Revenue Details Remain Undisclosed KW Q1 2026 Earnings EPS Surges Past Expectations Revenue Details Withheld DUO Q2 2021 Earnings Massive EPS Miss Highlights Continued Challenges ProCap Acquisition Corp Warrant PCAPW Holds Steady Near Support as Trading Activity Remains Subdued Giftify Inc GIFT Dips 334 as Stock Tests Key Support Near 080 Innoviz Technologies INVZ Slides Toward Support Amid Continued Selling Pressure Prelude Therapeutics PRLD Extends Gains Support Holds Resistance in Focus Expedia Group EXPE Softens as Travel Sector Faces Headwinds Key Levels to Watch Perpetua Resources Secures 29 Billion US Loan for Critical Minerals Project in Idaho AUR Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline BlackRock Income Trust BKT Gains Ground 1056 Tests Key Resistance Zone Prime Medicine Inc PRME Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Development Phase ELBM Q4 2025 Earnings Significant EPS Miss as PreRevenue Company Navigates Development Phase Instil Bio Q1 2026 Earnings EPS Miss as DevelopmentStage Company Reports No Revenue Stock Edges Up GLDD Q4 2025 Earnings Strong EPS Beat Despite Quiet Market Reaction PCB Bancorp PCB Q1 2026 Earnings EPS Surges Past Estimates Despite Slight Stock Dip WHD Q1 2026 Earnings EPS Beats Estimates by 861 Stock Edges Higher Vanda Pharmaceuticals Q1 2026 Earnings EPS Misses Estimates Stock Advances Despite Wider Loss